CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 77,3% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär Amgen AMGN

Sälj
 Köp

Amgen realtidsdiagram

5m 15m 30m 1h 4h 1d 1w

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Senaste nyheter

Visa mer
Frances Wang 2025 Jun 12, 16:00

Stellar (XLM) Price Analysis: Where could XLM go in the upcoming days?

Stocks
Frances Wang 2025 Jun 12, 16:00

Crypto News Today: Bitcoin Price Down 1.85% as US PPI Rises

Cryptocurrencies
Ghko B 2025 Jun 12, 16:00

Dogecoin Price Prediction: Could Dogecoin Price Surge to $0.95?

Cryptocurrencies
Tommy Yap 2025 Jun 12, 16:00

Morning Note: Middle East Conflict Shakes Markets as Oil Soars, While AI Sector Eyes Growth

Morning Note Oil NVDA Tech
Ghko B 2025 Jun 11, 16:00

Crypto Market Sentiment: Crypto Fear and Greed Index Today

Cryptocurrencies
Tommy Yap 2025 Jun 11, 16:00

Morning Note: Adobe’s AI Momentum Leads Market Moves with Gold and Fed in Focus

Morning Note Gold Commodities Stocks
Ghko B 2025 Jun 10, 16:00

BTC USD Price Prediction: How much will Bitcoin be worth in 2030?

Cryptocurrencies
Ghko B 2025 Jun 10, 16:00

Wells Fargo Stock Slides 1.32%: Is Wells Fargo stock a good buy now?

Stocks

Info

Spread

1.90

Spread (%)

0.6416 %

Hävstångseffekt

1:5

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaderna är stängda

Fredag

13:31 - 19:59

Måndag

13:31-19:59

Tisdag

13:31-19:59

Onsdag

13:31-19:59

Torsdag

13:31-19:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

156907978752

Utelöpande aktier

537705984

Rapportdatum (nästa)

1999-11-22

Utd-procent

2025-06-06

Datum efter utdelning

2025-05-16

Förväntad framtida årlig utdelningsprocent

9.52

Förväntad framtida årlig direktavkastning

0.0324

Vinst per aktie

10.91

Läs mer om detta instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)

Handla nu

Handla nu

Handla nu

Handla nu
Relaterade instrument

latest_education_articles

Visa mer
Trustpilot